BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, February 20, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

July 16, 2018

View Archived Issues

CARD-carrying AML killer

Read More

Cytokine gene therapy improves spinal cord regeneration

Read More

Metabolic differences of ApoE variants

Read More

APTO-253 is able to induce DNA damage in AML cells and can exploit BRCA1/2 recombination deficiency

Read More

Kelch-like family member 7: role in breast cancer progression and utility as prognostic marker

Read More

Rare, common genetic variants contribute to preterm birth

Read More

Landos Biopharma initiates phase I study of BT-11

Read More

CytoDyn to evaluate PRO-140 in cancer and immunological indications

Read More

ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine qualifies for phase II/III testing

Read More

Novel zebrafish models of Cantu syndrome using CrispR/Cas9-based nucleotide editing

Read More

Discovery of [18F]SWR-4-127, a novel PARP-1 selective 18F-PET tracer for neuroimaging

Read More

FDA lifts clinical hold on phase I/II combination study of axalimogene filolisbac plus durvalumab

Read More

Janssen patents OGA inhibitors

Read More

Idenix and Merck & Co. disclose anti-HIV-1 compounds

Read More

OBI Pharma initiates phase I study of OBI-888 in patients with solid tumors

Read More

University of Nebraska identifies NF-kappaB activation inhibitors

Read More

GlaxoSmithKline presents NRF2 activators

Read More

Atossa Genetics initiates phase II study of endoxifen in neoadjuvant breast cancer

Read More

FDA approves first drug to treat smallpox

Read More

Researchers find a relationship between prediabetes and overactive bladder

Read More

FDA approves Xtandi for nonmetastatic castration-resistant prostate cancer

Read More

RegenxBio begins first-in-human study with RGX-121 gene therapy for Hunter's syndrome

Read More

BGI-Shenzhen synthesizes new cancer vaccines

Read More

First-in-human study explores use of BAY-2287411 in mesothelin-expressing tumors

Read More

Brain-targeted gene editing using CRISPR-Gold in mice models of fragile X syndrome

Read More

MaxCyte's cleared to begin clinical study of CAR therapy MCY-M11

Read More

Popular Stories

  • Today's news in brief

    BioWorld
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld Science
    Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing